JPRN-UMIN000036940
Completed
未知
prostate biopsy based on transrectal ultrasound and MRI fusion imaging - MRI-US fusion prostate biopsy
Conditionsprostate cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- prostate cancer
- Sponsor
- Okayama University Hospital
- Enrollment
- 75
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •I. A patient who is judged not to contribute to a patient's life prognosis by a definite diagnosis of prostate cancer II. Patients suspected of developing prostate cancer with serum PSA\> 20 ng / ml III. Patients suspected of having advanced prostate cancer by rectal examination IV. Patients suspected of having advanced prostate cancer by MRI V. Patients who can not have prostate biopsy due to blood coagulation abnormality VI. Patients who can not be under spinal anesthesia, sacral anesthesia or general anesthesia because they have allergies to anesthetic agents VII. Other patients who were judged inappropriate by the doctor in charge of this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Examination about the usefulness in cancer localization diagnosis of prostate biopsy using BioJet systemprostate cancerJPRN-UMIN000037027Okayama University Hospital5
Completed
Not Applicable
TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY: PERIPROSTATIC BLOCK VERSUS CAUDAL BLOCK FOR ANALGESIA.AnaesthesiaPACTR202012779661309Oluwatobi Fasola80
Recruiting
Not Applicable
avigo™ MR-ultrasound fusion guided biopsiesprostate cancerNL-OMON27074Department of UrologyJeroen Bosch Hospital's-Hertogenbosch90
Not yet recruiting
Not Applicable
Transperineal prostate biopsy under local anaesthetic compared to general anaesthetic for men with suspected prostate cancerProstate cancerCancer - ProstateACTRN12620001145998Monash Health Department of Urology620
Completed
Not Applicable
Transperineal Versus Transrectal Prostate BiopsyProstate CancerNCT06027203Maastricht University Medical Center923